Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsMotion SicknessCisplatinDoxorubicinCyclophosphamideBreast NeoplasmsCombined Modality TherapyTreatment OutcomeNauseaNeoplasmsLung NeoplasmsPaclitaxelDrug Resistance, NeoplasmVomitingNeoplasm StagingCarboplatinMedical OncologyPrognosisDisease-Free SurvivalSurvival AnalysisDrug Administration ScheduleTaxoidsSurvival RateColorectal NeoplasmsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsNeoplasm Recurrence, LocalFatigueNeoplasm MetastasisQuality of LifeFluorouracilCell Line, TumorNeoadjuvant TherapyTime FactorsEtoposideProspective StudiesDisease ProgressionApoptosisMethotrexateRetrospective StudiesInduction ChemotherapyVinblastineQuestionnairesIfosfamideBleomycinDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyFollow-Up StudiesTesticular NeoplasmsNeutropeniaTransplantation, AutologousAdenocarcinomaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseRadiotherapyAntibiotics, AntineoplasticDacarbazineClinical Trials as TopicNeoplasms, Germ Cell and EmbryonalCarmustineLomustineGranulocyte Colony-Stimulating FactorCamptothecinKaplan-Meier EstimatePlatinum CompoundsBrain NeoplasmsBone NeoplasmsInfusions, Intra-ArterialOsteosarcomaMelphalanLeukopeniaAntiemeticsMitomycinThiotepaTumor Markers, BiologicalLiver NeoplasmsHematopoietic Stem Cell TransplantationDrug TherapyPeritoneal NeoplasmsMitoxantroneInfusions, IntravenousLymphatic MetastasisRecurrenceStomach NeoplasmsDose-Response Relationship, DrugTegafurPalliative CareAntibodies, Monoclonal, HumanizedGerminomaRadiotherapy Dosage